记录两组血管活性药物的使用情况。
休克型以扩充血容量，纠正酸中毒基础上加用血管活性药物。
The treatment of shock type is based on the rectification of acid intoxication and use vascular active medicine to enlarge the blood capacity.
用血管活性药物改善微循环，维持水、电解质和酸碱平衡，补充营养。
Use of vasoactive drugs in microcirculation and maintain water, electrolyte and acid-base balance, nutritional supplements.
结论确诊需结合临床和辅助检查，治疗应采取综合措施，必要时使用激素、血管活性药物。
Conclusion It is necessary to combine clinical materials and assistant examination to make the diagnosis, and to use combined therapy, including corticosteroid and vasoactive drugs.
方法：回顾分析我院近年来以腹水直接回输，合并应用血管活性药物治疗肝肾综合征的资料。
Methods: The data of treatment of hepatorenal syndrome by ascites back transfusion combined with vasoactive substance was retrospectively analyzed.
目的探讨当使用微量泵泵入血管活性药物时，避免因更换注射器而造成血压明显波动的微量泵使用方法。
Objective To explore the methods for avoiding obvious fluctuation of blood pressure during the change of the injector when pumping the active drugs of blood vessels with a micro-infusion pump.
切除肿瘤时有创动脉监测血压、心率明显波动，适时采用血管活性药物调整血压和心率，手术过程顺利。
The invasive blood pressure and heart rate of the patients were significantly changed during operation, which were treated with vasoactive drugs. The operation was uneventful.
方法 ：我们对连续89例RCVS患者的数据进行了前瞻性分析，其中8例发生于产后，46例使用过血管活性药物。
Methods— We analyzed prospective data on 89 consecutive patients with RCVS, of which 8 were postpartum and 46 used vasoactive substances.
根据血液动力学参数和临床表现分型标准，给予血管活性药物的治疗，对预后有了明确估计，对我们临床上开展心脏外科治疗有一定指导价值。
According to the hemodynamic parameters and the criterion for clinical typing, the vasoactive agents therapy can provide a precise prognosis and the therapy is of certain value in cardiac surgery.
根据血液动力学参数和临床表现分型标准，给予血管活性药物的治疗，对预后有了明确估计，对我们临床上开展心脏外科治疗有一定指导价值。
According to the hemodynamic parameters and the criterion for clinical typing, the vasoactive agents therapy can provide a precise prognosis and the therapy is of certain value in cardiac surgery.
应用推荐